US (OH): Medical cannabis industry wary of growth as demand lags

Inside a large, pristine facility at Buckeye Lake, PharmaCann is growing just under 25,000 square feet of marijuana − almost half the size of a football field.

Rooms are filled with nearly 4,500 cannabis plants at different stages that will eventually be sold as flower or processed into edibles or vapes. And PharmaCann could go bigger if it wanted. Under its license with the state, the company is allowed to cultivate up to 50,000 square feet at the central Ohio facility.

But PharmaCann officials say the numbers don't add up. They believe there's too much supply and not enough demand from patients, many of whom skip the bureaucracy and drive to Michigan for cheaper marijuana. Growing any more in the current market wouldn't work for the company's bottom line, said Jeremy Unruh, vice president of public and regulatory affairs.

"When you're growing at a loss, you're producing at a loss in an over-saturated market, your ability to do anything but put out your cheapest product is constrained," Unruh said.


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.